This Fund Manager Rating is based on the Citywire Long Only ratings methodology
Citywire Ratings are rewarded for risk adjusted outperformance of benchmarks we select independently More information on how Ratings are calculated
About Evan McCulloch
Evan McCulloch joined Franklin Templeton Investments as a management trainee in 1992. Now a vice president and portfolio manager for the group, McCulloch’s responsibilities include managing the Franklin Biotechnology Fund. A self described research driven investor, McCulloch specialises in research analysis of the health care industry; including pharmaceuticals, health care information systems/internet and health care providers. He is a bottom-up investor who pursues a growth strategy and focuses primarily on individual securities, choosing companies he believes are positioned for rapid growth in revenues, earnings or assets. Born in Mesa, Arizona in 1969, McCulloch graduated from the University of California at Berkeley with a bachelor’s degree in economics and business administration.
Citywire Rating: Not Rated
|2||Rudi Van den Eynde||11.1%|
|View full league table|
Month by Month Performance